Ken Janoski

Ken Janoski currently serves on the MTEC Ventures Investment Council at the Medical Technology Enterprise Consortium and as a Strategic Advisor and member of the Business Advisory Board at NeuroGT, Inc., a UNC-spinout focused on developing gene therapies for rare neurogenic diseases. Janoski has held senior investment roles, including Senior Director of Investments at the North Carolina Biotechnology Center and Managing Partner at Guidance Ventures. Prior experience includes leadership positions at BioGenerator, SynBioX, Innovate Biosciences, and Aureozyme, as well as a role as Director at Andersen Consulting. Janoski's educational background includes advanced studies in Venture Capital Finance from the University of California, Berkeley, and an MBA in Finance from Washington University in St. Louis, complemented by a B.S. in Business Administration from the University of Missouri-Saint Louis.